What's New
FTD in the News
Study Finds Suicidal Thoughts Likelier in People with Dementia, Calls for Better Supports
A study conducted by researchers at University College London (UCL) published in the journal Ageing Research Reviews…
AFTD Ambassador Shares Her Family’s FTD Story with Massachusetts Newspaper
Dawn O’Gara, an ATD Ambassador, spoke about her beloved father’s FTD diagnosis and how it spurred her…
Astellas and AviadoBio Announce Exclusive License Agreement for FTD-GRN Gene Therapy
Astellas Pharma and AviadoBio have announced an exclusive license agreement for AVB-101, an experimental gene therapy for…
Study Finds That FTD and ALS Have Similar Cellular and Molecular Characteristics
A study by MIT and Mayo Clinic researchers published in the Cell journal finds that FTD and…
The Power of Advocacy
AFTD would like to highlight the power of advocacy in contributing to the greater awareness of FTD….
Psilera Announces Positive Preclinical Data for FTD Intervention Candidate
Biotechnology company Psilera announced positive preclinical data for its FTD drug candidate, moving it another step towards…
When One Voice Sounds Like a Chorus: Dawn Kirby’s Relentless Campaign to Raise FTD Awareness
Dawn Kirby and her husband, Tim, are getting the word out about FTD. The couple were recently…
AFTD Volunteer Secures 3 FTD Awareness Week Proclamations in Ohio
Lima, Ohio is the most recent community to officially proclaim September 22-29 as FTD Awareness Week. Resident…
Medical Technology CEO Discusses Using EEG to Differentiate FTD and Alzheimer’s
In an interview with Neurology Live, Advanced Brain Monitoring CEO Chris Berka shares insights from a pilot…
A Conversation with Juan Chavez, MD, of Passage Bio
AFTD recently spoke with Passage Bio Vice President of Clinical Development Juan Chavez, MD, about the company’s…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)